Antiretroviral therapy coverage for PMTCT in IDA only
IDA only: Antiretroviral therapy coverage for PMTCT was 85.9% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in IDA only, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
IDA only recorded 85.9% for antiretroviral therapy coverage for pmtct in 2024.
The figure is up 1.2% on the previous year and up 11.3% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in IDA only peaked at 86.9% in 2019 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in IDA only, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.2% | +986.0% |
| 2003 | 1.7% | +662.1% |
| 2004 | 5.7% | +243.4% |
| 2005 | 12.6% | +120.1% |
| 2006 | 19.5% | +54.1% |
| 2007 | 34.2% | +75.5% |
| 2008 | 44.5% | +30.1% |
| 2009 | 53.3% | +19.8% |
| 2010 | 35.9% | -32.7% |
| 2011 | 52.4% | +46.1% |
| 2012 | 68.5% | +30.6% |
| 2013 | 72.8% | +6.4% |
| 2014 | 77.2% | +6.0% |
| 2015 | 79.0% | +2.3% |
| 2016 | 78.6% | -0.6% |
| 2017 | 82.7% | +5.3% |
| 2018 | 84.5% | +2.2% |
| 2019 | 86.9% | +2.9% |
| 2020 | 85.8% | -1.4% |
| 2021 | 84.2% | -1.8% |
| 2022 | 82.9% | -1.5% |
| 2023 | 84.9% | +2.4% |
| 2024 | 85.9% | +1.2% |
Biggest year-on-year movements
Years where Antiretroviral therapy coverage for PMTCT in IDA only changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2002 | +986.0% | 0.0% | 0.2% |
| 2003 | +662.1% | 0.2% | 1.7% |
| 2004 | +243.4% | 1.7% | 5.7% |
| 2005 | +120.1% | 5.7% | 12.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 17.2% | 0.0% | 53.3% | 10 |
| 2010s | 71.9% | 35.9% | 86.9% | 10 |
| 2020s | 84.7% | 82.9% | 85.9% | 5 |
Countries ranked near IDA only
More health data for IDA only
- Population ages 0-14, total, per capita 0.3746 units per person (2025)
- Population, male, per capita 0.4965 units per person (2025)
- Population ages 15-64, male, per capita 0.2881 units per person (2025)
- Population ages 15-64, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 15-64, male, annual growth rate 2.63 % change on previous year (2025)
- Population ages 15-64, female, per capita 0.2964 units per person (2025)
- Population ages 15-64, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population, male 49.7% (2025)
- Population ages 15-64, female, annual growth rate 2.54 % change on previous year (2025)
- Population ages 0-14, male, per capita 0.1902 units per person (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in IDA only?
- Antiretroviral therapy coverage for pmtct in IDA only was 85.9% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in IDA only?
- The highest recorded value was 86.9% in 2019.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in IDA only?
- The lowest recorded value was 0.0% in 2000.
- How does IDA only rank for antiretroviral therapy coverage for pmtct?
- IDA only ranks 5th out of 15 groups with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in IDA only?
- Over the last ten years it is up 11.3%. The long-run trend across the full record is volatile.
- Where does this IDA only data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).